BRIEF-TELA Bio Q3 Revenue USD 18.957 Million Vs. IBES Estimate USD 18.9 Million

Reuters
08 Nov 2024

Nov 07 (Reuters) - TELA Bio Q3 income from operations USD -9.365 million. * Q3 net income USD -10.372 million * Q3 operating expenses USD 22.223 million * Q3 basic EPS USD -0.42 * Q3 gross profit USD 12.858 million * outlook FY revenue USD 74.5-76.5 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10